STOCK TITAN

Avanos Medical, Inc. to Present at the Virtual Raymond James 42nd Annual Institutional Investors Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

ALPHARETTA, Ga., Feb. 24, 2021 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, senior vice president and chief financial officer, will present at the Virtual Raymond James 42nd Annual Institutional Investors Conference Mon., March 1 at approximately 3:50 p.m., ET

A live webcast of conference presentation will be available on the Investors section of the Avanos Medical website and will be archived on that site.

About Avanos Medical:
Avanos Medical (NYSE: AVNS) is a medical technology company focused on delivering clinically superior breakthrough medical device solutions to improve patients' quality of life. Headquartered in Alpharetta, Georgia, Avanos is committed to addressing some of today's most important healthcare needs, such as reducing the use of opioids while helping patients move from surgery to recovery. Avanos develops, manufactures and markets its recognized brands in more than 90 countries. For more information, visit www.avanos.com and follow Avanos Medical on Twitter (@AvanosMedical), LinkedIn and Facebook.

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/avanos-medical-inc-to-present-at-the-virtual-raymond-james-42nd-annual-institutional-investors-conference-301234334.html

SOURCE Avanos Medical

Avanos Medical, Inc.

NYSE:AVNS

AVNS Rankings

AVNS Latest News

AVNS Stock Data

868.18M
39.28M
2.84%
99.42%
2.56%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
ALPHARETTA

About AVNS

avanos is a medical device company focused on delivering clinically superior breakthrough solutions that will help patients get back to the things that matter.headquartered in alpharetta, georgia, avanos is committed to creating the next generation of innovative healthcare solutions which will address our most important healthcare needs, such as reducing the use of opioids while helping patients move from surgery to recovery.avanos develops, manufactures and markets its recognized brands in more than 90 countries.